Advertisement

Topics

Companies Related to "A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers" [Most Relevant Company Matches] RSS

20:00 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers" found in our extensive corporate database of over 50,000 company records.

Showing "Multiple Dose Study 04620110 Overweight Obese Otherwise Healthy" Companies 1–25 of 2,400+

Relevant

Ameritox

The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...


MEND Foundation

In the US, the MEND Foundation is an independent non-profit whose mission it is to serve low-income children in underserved communities. MEND Programs run in collaboration with the YMCA and other community partners and are currently available in California, Washington DC, Texas and New York. The MEND (Mind, Exercise, Nutrition...Do it!) Program was establi...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


ReShape Medical, Inc.

ReShape Medical® (www.reshapemedical.com) is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients. ReShape Duo is a non-surgical alternative designed for those who have exhausted th...

Gen YOUth Foundation

Today, over one-third of American children are either overweight or obese. If the trend continues, today's children may be the first generation with shorter life expectancies than their parents. In response to this epidemic, Gen YOUth Foundation was founded to inspire youth behavior change. Gen YOUth Foundation is launched with initial funding from four founding partners: Domino's Pizza®, Kraft F...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

Beko

Beko will not only inspire and raise awareness about the global challenge of obesity in childhood, but has a goal to raise €1,000,000 for UNICEF by encouraging people all over the world to share their healthy eating habits on social media. For each #EatLikeAPro post that appears on Instagram or Twitter, Beko will donate €1 for UNICEF. The donatio...

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...

Hollis-Eden Pharmaceuticals, Inc.

Hollis-Eden Pharmaceuticals is a development-stage company with two product candidates in clinical trials: Apoptone® (HE3235), in the dose-escalation portion of a Phase I/II trial of patients with late-stage prostate cancer, and Triolex®, in a Phase IIa trial in obese type 2 diabetes mellitus patients. Apoptone® and Triolex® represent the lead candidates from Hollis-Eden's small molecule pla...

The Surgical Weight Control Center of Nevada

The Surgical Weight Control Center of Nevada has been helping severely overweight people since 1989. If you are severely overweight, we hope that you find this Web site informative and helpful in assisting your decision to have surgery. As you review the information here, we hope you understand who can benefit from this form of therapy, the pros and cons of the various operations being performed, ...

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

GammaWest Brachytherapy

Brachytherapy is an advanced cancer treatment. The word "brachy" is Greek for "close by" and refers to placing radioactive seeds or sources directly in the tumor. This procedure gives physicians and patients the important advantage of applying a higher dose of radiation directly to the tumor while sparing healthy tissue and surrounding organs. Brachytherapy is a localized, precise, radiation treat...

Slimming World USA Online

Slimming World is Britain’s largest and most advanced slimming organization. It was founded in 1969 to offer people a very different approach to weight loss: a hunger-busting healthy eating plan based on satiety and energy density, an activity program to suit individual needs, and group support that offers compassion and understanding. Slimming World ...

Ziarco

Ziarco is a clinical-stage biotechnology company developing innovative therapeutics targeting inflammatory and allergic diseases. The company’s product pipeline includes ZPL-3893787, an H4 receptor antagonist that has completed a Phase 1 multiple ascending dose study. A second clinical-stage, programme targets inflammatory disorders by inhibiting cyto...

Broncho-Dose

Broncho-Dose Pharmacy provides home-delivered nebulizer medications. Our team of pharmacy specialists provides an outstanding level of customer service to respiratory patients nationwide.

Population Association of America (PAA)

The Population Association of America (PAA) is a nonprofit, scientific, professional organization established in 1930 to support the scientific study of the human population. PAA is an organization of professionals from multiple disciplines including demographers, sociologists, economists, public health professionals, and other engaged in resea...

Fresh Healthy Vending International, Inc.

Fresh Healthy Vending, based in San Diego, California, is North America’s leading healthy vending franchisor. Fresh Healthy Vending pioneered the concept of vending machines stocked with tried-and-tested fresh, healthy snack options and capitalizes on a growing market of health conscious consumers. The company has appointed more than 205 franchisees t...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Bespak Europe

Bespak, founded more than 40 years ago, has established a reputation as a leading supplier of drug delivery technologies and services to the pharmaceutical and biotechnology industries.The company’s comprehensive capabilities have enabled it to develop proprietary drug delivery devices and technologies, many protected by worldwide patents. These include pressurised metered dose inhalers and actu...

Jennerex, Inc.

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two mid-stage clinical trials in patients with primary liver cancer -- an international, randomized, Phase 2 dose-response clinical trial, and a Phase 2 study in combina...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary needle-free solid dose injector, the Glide SDI(R).

Multiple Myeloma Research Foundation (MMRF)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2010, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.

The Multiple Myeloma Research Consortium (MMRC)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2011, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.


More From BioPortfolio on "A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy Volunteers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks